PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 153 filers reported holding PROTAGONIST THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $591,106 | +49.0% | 35,438 | +146.6% | 0.02% | +53.3% |
| Q2 2023 | $396,844 | -74.5% | 14,368 | -78.8% | 0.02% | -76.9% |
| Q1 2023 | $1,557,100 | +246.8% | 67,700 | +27.3% | 0.06% | +261.1% |
| Q3 2022 | $449,000 | +10.9% | 53,190 | +3.8% | 0.02% | +5.9% |
| Q2 2022 | $405,000 | -51.1% | 51,264 | +46.5% | 0.02% | -52.8% |
| Q1 2022 | $829,000 | -34.7% | 35,000 | -5.7% | 0.04% | -55.0% |
| Q4 2021 | $1,269,000 | – | 37,100 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $43,400,000 | 3.81% |
| BVF INC/IL | 3,901,759 | $69,139,000 | 2.70% |
| COMMODORE CAPITAL LP | 498,079 | $8,826,000 | 2.33% |
| Altium Capital Management LP | 346,000 | $6,131,000 | 1.61% |
| Twin Lakes Capital Management, LLC | 139,287 | $2,468,000 | 1.45% |
| Opaleye Management Inc. | 330,222 | $5,852,000 | 1.09% |
| EcoR1 Capital, LLC | 1,443,800 | $25,584,000 | 0.89% |
| OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | 776,689 | $13,763,000 | 0.76% |
| JABODON PT CO | 90,656 | $1,606,000 | 0.66% |
| Artal Group S.A. | 1,500,000 | $26,580,000 | 0.60% |